Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 77

1.

Oral fingolimod for chronic inflammatory demyelinating polyradiculoneuropathy (FORCIDP Trial): a double-blind, multicentre, randomised controlled trial.

Hughes R, Dalakas MC, Merkies I, Latov N, Léger JM, Nobile-Orazio E, Sobue G, Genge A, Cornblath D, Merschhemke M, Ervin CM, Agoropoulou C, Hartung HP.

Lancet Neurol. 2018 Jul 6. pii: S1474-4422(18)30202-3. doi: 10.1016/S1474-4422(18)30202-3. [Epub ahead of print]

PMID:
30001923
2.

N-hexane exposure: a cause of small fiber neuropathy.

Guimarães-Costa R, Schoindre Y, Metlaine A, Lefaucheur JP, Camdessanché JP, Maisonobe T, Léger JM.

J Peripher Nerv Syst. 2018 Jun;23(2):143-146. doi: 10.1111/jns.12261. Epub 2018 Mar 26.

PMID:
29542204
3.

Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features.

Svahn J, Petiot P, Antoine JC, Vial C, Delmont E, Viala K, Steck AJ, Magot A, Cauquil C, Zarea A, Echaniz-Laguna A, Iancu Ferfoglia R, Gueguen A, Magy L, Léger JM, Kuntzer T, Ferraud K, Lacour A, Camdessanché JP; Francophone anti-MAG cohort Group.

J Neurol Neurosurg Psychiatry. 2018 May;89(5):499-505. doi: 10.1136/jnnp-2017-316715. Epub 2017 Oct 25.

PMID:
29070644
4.

230th ENMC International Workshop:: Improving future assessment and research in IgM anti-MAG peripheral neuropathy: A consensus collaborative effort, Naarden, The Netherlands, 24-26 February 2017.

Pruppers MHJ, Merkies ISJ, Lunn MPT, Notermans NC; IMAGiNe Study Group.

Neuromuscul Disord. 2017 Nov;27(11):1065-1072. doi: 10.1016/j.nmd.2017.08.001. Epub 2017 Aug 2. No abstract available.

PMID:
28927829
5.

Muscle, neuromuscular junction and peripheral nerve diseases.

Léger JM.

Curr Opin Neurol. 2017 Oct;30(5):447-448. doi: 10.1097/WCO.0000000000000485. No abstract available.

PMID:
28731862
6.

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial.

Merkies ISJ, Lawo JP, Edelman JM, De Bleecker JL, Sommer C, Robberecht W, Saarela M, Kamienowski J, Stelmasiak Z, Mielke O, Tackenberg B, Léger JM; PRIMA trial investigators.

J Peripher Nerv Syst. 2017 Jun;22(2):149-152. doi: 10.1111/jns.12204. No abstract available.

PMID:
28594116
7.

Editorial: introducing the new Co-Editors-in-Chief of Current Opinion in Neurology.

Eidelberg D, Léger JM.

Curr Opin Neurol. 2017 Jun;30(3):207. doi: 10.1097/WCO.0000000000000459. No abstract available.

PMID:
28402992
8.

Too Often Forgotten: Passive Transfer of Antibodies.

Thibault V, Pinte L, Vergez J, Leger JM, Liou A.

Clin Infect Dis. 2016 Sep 1;63(5):709-10. doi: 10.1093/cid/ciw337. Epub 2016 May 20. No abstract available.

PMID:
27208043
9.

[Beware of immunoglobulin's passive transfer when interpreting serological analyses!].

Pinte L, Vergez J, Liou A, Leger JM, Thibault V.

Presse Med. 2016 Jul-Aug;45(7-8 Pt 1):676-81. doi: 10.1016/j.lpm.2016.03.009. Epub 2016 Apr 28. French.

PMID:
27132942
10.

Identifying a therapeutic window in acute and subacute inflammatory sensory neuronopathies.

Antoine JC, Robert-Varvat F, Maisonobe T, Créange A, Franques J, Mathis S, Delmont E, Kuntzer T, Lefaucheur JP, Pouget J, Viala K, Desnuelle C, Echaniz-Laguna A, Rotolo F, Camdessanché JP; French Neuromuscular Network FILNEMUS.

J Neurol Sci. 2016 Feb 15;361:187-91. doi: 10.1016/j.jns.2015.12.044. Epub 2015 Dec 29.

PMID:
26810539
11.

Long-term efficacy of rituximab in IgM anti-myelin-associated glycoprotein neuropathy: RIMAG follow-up study.

Iancu Ferfoglia R, Guimarães-Costa R, Viala K, Musset L, Neil J, Marin B, Léger JM.

J Peripher Nerv Syst. 2016 Mar;21(1):10-4. doi: 10.1111/jns.12156.

PMID:
26748872
12.

[Suicide headache].

Donnet A, Leger JM.

Presse Med. 2015 Nov;44(11):1170. doi: 10.1016/j.lpm.2015.11.001. French. No abstract available.

PMID:
26615084
13.

Immunotherapy in Peripheral Neuropathies.

Léger JM, Guimarães-Costa R, Muntean C.

Neurotherapeutics. 2016 Jan;13(1):96-107. doi: 10.1007/s13311-015-0401-7. Review.

14.

Genotype-phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France.

Mariani LL, Lozeron P, Théaudin M, Mincheva Z, Signate A, Ducot B, Algalarrondo V, Denier C, Adam C, Nicolas G, Samuel D, Slama MS, Lacroix C, Misrahi M, Adams D; French Familial Amyloid Polyneuropathies Network (CORNAMYL) Study Group.

Ann Neurol. 2015 Dec;78(6):901-16. doi: 10.1002/ana.24519. Epub 2015 Oct 7.

15.

Amyotrophic lateral sclerosis, channelopathies and peripheral neuropathies: current status and new perspectives.

Léger JM.

Curr Opin Neurol. 2015 Oct;28(5):453-4. doi: 10.1097/WCO.0000000000000247. No abstract available.

PMID:
26356409
16.

Non HCV-related infectious cryoglobulinemia vasculitis: Results from the French nationwide CryoVas survey and systematic review of the literature.

Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, Graffin B, Hot A, Kahn JE, Michel C, Quemeneur T, de Saint-Martin L, Hermine O, Léger JM, Mariette X, Senet P, Plaisier E, Cacoub P.

J Autoimmun. 2015 Dec;65:74-81. doi: 10.1016/j.jaut.2015.08.008. Epub 2015 Aug 29. Review.

PMID:
26320984
17.

Spectrum and Prognosis of Noninfectious Renal Mixed Cryoglobulinemic GN.

Zaidan M, Terrier B, Pozdzik A, Frouget T, Rioux-Leclercq N, Combe C, Lepreux S, Hummel A, Noël LH, Marie I, Legallicier B, François A, Huart A, Launay D, Kaplanski G, Bridoux F, Vanhille P, Makdassi R, Augusto JF, Rouvier P, Karras A, Jouanneau C, Verpont MC, Callard P, Carrat F, Hermine O, Léger JM, Mariette X, Senet P, Saadoun D, Ronco P, Brochériou I, Cacoub P, Plaisier E; CryoVas study group.

J Am Soc Nephrol. 2016 Apr;27(4):1213-24. doi: 10.1681/ASN.2015020114. Epub 2015 Aug 10.

18.

Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases.

Chapelon-Abric C, Saadoun D, Biard L, Sene D, Resche-Rigon M, Hervier B, Costedoat-Chalumeau N, Drier A, Leger JM, Cacoub P.

Clin Exp Rheumatol. 2015 Jul-Aug;33(4):509-15. Epub 2015 Jun 29.

PMID:
26120779
19.

Grip strength comparison in immune-mediated neuropathies: Vigorimeter vs. Jamar.

Draak TH, Pruppers MH, van Nes SI, Vanhoutte EK, Bakkers M, Gorson KC, Van der Pol WL, Lewis RA, Notermans NC, Nobile-Orazio E, Léger JM, Van den Bergh PY, Lauria G, Bril V, Katzberg H, Lunn MP, Pouget J, van der Kooi AJ, van den Berg LH, van Doorn PA, Cornblath DR, Hahn AF, Faber CG, Merkies IS; PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):269-76. doi: 10.1111/jns.12126.

PMID:
26115516
20.

Outcome measures in MMN revisited: further improvement needed.

Pruppers MH, Draak TH, Vanhoutte EK, Van der Pol WL, Gorson KC, Léger JM, Nobile-Orazio E, Lewis RA, van den Berg LH, Faber CG, Merkies IS; PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):306-18. doi: 10.1111/jns.12124.

PMID:
26115442

Supplemental Content

Loading ...
Support Center